The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.

In stable patients without heart failure, discontinuing beta-blockers 1 year after a heart attack was noninferior to ...

The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help ...

The SMART-DECISION trial has found that in stabilized patients after myocardial infarction (MI) without heart failure or left ventricular systolic dysfunction, discontinuing beta-blockers after one ...

In this analysis, researchers evaluated whether beta blocker use is associated with improved survival in patients with solid tumors.

People who have had a heart attack may be able to safely discontinue beta-blocker use after a year if they are at low-risk ...

Beta blockers as monotherapy or first-line therapy were evaluated in a Cochrane review of 13 randomized trials with a total of 91,561 adults (Cochrane Database Syst Rev. 2007;[1]:CD002003) and were ...

London, United Kingdom – 30 August 2024: The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI ...